ArticleSTAR protocols2026

Protocol to define the in situ proteome of endogenous PRC2 bodies in the triple-negative breast cancer cell line BoM-1833 using optoproteomics.

Yu-Chih Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.